Commercial conflict of interest and medical publication: What should the practising physician do about it.
Indian J Med Ethics
;
2016 Oct-Dec; 1 (4): 227-228
Article
in English
| IMSEAR
| ID: sea-180303
ABSTRACT
I read with interest the comment by Mark Wilson, which deals with possible conflict of interest (CoI) affecting publications in academic medical journals. This comment has specifically targeted the New England Journal of Medicine (NEJM) and its editor-in-chief Jeffrey Drazen on the “Vioxx scandal” which broke 15 years ago. Wilson’s comment seems to be in response to a blog by Natarajan on CoI in medical publications. In the blog Natarajan writes of commercial CoI biasing publication of clinical trials and cites, among other examples, a publication in the NEJM on trials of voriconazole.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Language:
English
Journal:
Indian J Med Ethics
Journal subject:
Ethics
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS